Examples of the way our solutions benefit organisations

We offer several ways of working, from direct access to GPI pulse or collaborating on projects with our Consulting team, GPI delivers the highest quality data required for the multiple aspects of pricing and market access. Our solution supports a modern approach that applies data-driven decision making to drug development from early pipeline to product launch and indication expansion.

Forecasting price corridors through price-value perception framework
Client Challenge

Our client was looking for a different set of inputs to justify price levels in price negotiation, as well as sense-checking the findings from more traditional pricing research such as payer and KOL interviews.

Our Solution

GPI created a price model that considered analogue information, HTA data and prices that could be used to asses the relationship between HTA and pricing as well as provide insights into price positioning or price level expectations for new products.

 

Outcome

Based on GPI’s model, our client gained an evidence-based insight into how HTA and prices may be linked.  The findings from the analysis provided a clear outline of key analogue value – price relationships and helped our client to complete the strategic puzzle to position and optimise list prices and anticipate net pricing.

Competitor landscape assessment
Client Challenge

A global pharmaceutical company needed to assess the current and future competitive landscape of an early-stage analog drug to determine the possibilities of market entry and the viability of possible differentiation strategies to compete in the market.

Our Solution

Our team researched and analyzed direct competitors and the current standard of care drugs. GPI pulse provided detailed landscape environment of the identified products including prices, reimbursement pathways, time to reimbursement aiding the valuation of the asset.

On-going quarterly updates and summaries were provided aiding market movements.

Outcome

The client was able to quickly digest competitive threats and opportunities and understand the possible role their drug could play in the developing landscape. The information highlighted areas of potential pitfalls and competitor reactions.

 

Commercial forecasting
Client Challenge

The project brief was to address several different forecasting needs to capture all aspects of a global product launch across multiple indications and patient groups. Our client was particularly looking to obtain a tool to address financial, market access as well as manufacturing forecasting needs across launch and beyond.

Our Solution

GPI created a global commercial forecast model in Excel that was flexible to incorporate several indications, distinguish different patient groups and market requirements. Competitor assumption, market access programmes and pricing approaches were incorporated. The tool provided sales, revenues and demand modelling as well as scenario analyses with monthly and yearly outputs.

Outcome

The model provided our client with powerful insights to estimate sales and revenue, plan for demand and manufacturing. Model outputs were used for senior management reporting, budgeting, launch and manufacturing planning. Additionally, scenarios analysis helped to evaluate different commercial strategies. The model was flexible enough to be updated and adjust as launch progressed.

IRP analysis
Client Challenge

Managing and understanding the impact of international reference pricing (IRP) is challenging, with multiple possible price scenarios and permutations. Our clients was looking for support in understanding IRP impact and related decision making for one of their global products.

Our Solution

GPI  delivered a bespoke Excel-based IRP calculation tool to determine and optimise price and revenue impact on a global scale, including reliable price data, reference rules, references time points and currency exchange rates.

Training sessions to kick-start tool roll-out and encourage use across a global team were conducted by the GPI team.

Outcome

Our client obtained a user-friendly tool to evaluate the pricing impact  across global markets. The IRP calculator continues to provide key insights to optimise the commercial potential of a global brand.

The training sessions helped to encourage adoption and familiarise users with all aspects of the calculator.

Launching across indications in a competitve, fast moving space
Client Challenge

Our client was launching a new drug in phase III in a crowded space and need reliable and timely insights to stay ahead of the market.

Scope: 50 countries

Our Solution

Using GPI pulse, the company was able to review all pricing, reimbursement, regulatory and market access insights for drugs already launched with same mechanism of action and indication.

Applying all this information, the client was able to determine the pricing and access landscape with detailed descriptions of gold standard and benchmarks against peers and best practice companies.

The client also had access to real-time news alerts to help them stay up to date with the latest market developments

Outcome

Client had a robust understanding of the data and arguments presented and payer decisions at the click of the button.

The insights enabled decision making and helped the client understand pricing, endpoints, comparators, payer interests and cost of each treatment option saving time and cost of a consulting engagement. They were able to answer questions like:

Identify the pricing strategy adopted by other competitors with the same mechanism of action

Is there a price premium for “me too” medicines or is there a linear pricing structure?

Gather all HTA assessments across the globe

Are all drugs with same mechanism of action recommended if the cost per day is the same? Do any of the drugs provide a patient access scheme? What was the price reduction after an IQWIG assessment?

Analyse the time to reimbursement

Is the same time for all drugs? In what countries did it take more time?

Innovative Tender Tool-kit and Model
Client Challenge

Our client required an innovative approach to managing tender processes and bids across countries with the end goal of optimising outcomes

  • Scope: 15 countries across 4 regions
Our Solution

Applying all this information, the client was able to determine the pricing and access landscape with detailed descriptions of gold standard and benchmarks against peers and best practice companies.

Outcome

Based on GPI’s model, our client gained an evidence-based insight into how HTA and prices may be linked.  The findings from the analysis provided a clear outline of key analogue value – price relationships and helped our client to complete the strategic puzzle to position and optimise list prices and anticipate net pricing.